- What is the CD33-directed Immunoconjugate drug class?
- CD33-directed Immunoconjugate is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 1 CD33-directed Immunoconjugate product, each independently rated.
- What conditions do CD33-directed Immunoconjugate drugs treat?
- Per FDA drug-label data, CD33-directed Immunoconjugate drugs are used for conditions including leukemia, myeloid, acute, leukemia, myelomonocytic, acute.
- Which CD33-directed Immunoconjugate drug is best-rated?
- By our independent rating, mylotarg currently ranks highest among CD33-directed Immunoconjugate drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.